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Abstract We studied counselees’ expressed understanding of
the risk estimate and surveillance recommendation in the final
consultation for breast cancer genetic counseling in relation
with their risk perception, worry and cancer surveillance ad-
herence 1 year post-counseling. Consecutive counselees were
included from 2008 to 2010. Counselees with an indication
for diagnostic DNA-testing for themselves or a breast cancer
affected relative were requested to complete online question-
naires before and after counseling and one year after counsel-
ing (N=152–124). Self-reported surveillance was compared
to surveillance recommendations. Consultations were
videotaped. Counselees’ reactions to the risks and recommen-
dations were coded. Statements about the risk perception and
surveillance intentions of breast cancer unaffected counselees
were transcribed. Associations with outcomes were explored.
Almost all breast cancer unaffected counselees (>90 %)
reacted to their risk estimate with an utterance indicating
understanding and this reaction was not significantly associ-
ated with their post-visit risk perception alignment. Over one-
third (38.6 %) overestimated their risk post-counseling. Few
counselees (5.8 %) expressed surveillance intentions. One
year after counseling, about three-quarters (74.0 %) of the
breast cancer unaffected counselees had adhered to the sur-
veillance recommendation. Almost one-quarter (23.3 %) had
performed more mammograms/MRI scans than recommend-
ed, which was associated with prior mammography uptake
(n=47; X2=5.2; p=.02). Counselees’ post-counseling overes-
timation of their risk, high levels of worry and high surveil-
lance uptake were not reflected in their reactions to the coun-
selor’s information during the final visit.
Keywords Breast cancer .Geneticcounseling .Surveillance .
Mammography . Adherence . Risk perception
Introduction
Breast cancer genetic counseling aims to promote informed
decision making concerning surveillance of those at increased
risk of (hereditary) breast cancer (Resta et al. 2008).
Counselees can be referred by their general practitioner (GP)
or consultant. Genetic counseling might entail one or more
visits and a DNA-test. The genetic counselor provides a risk
estimate and surveillance recommendation to help the coun-
selee understand her risk and adapt to it. However, genetic
counseling appears to have little impact on counselees’ per-
ception of their own and their relatives’ risk (Butow et al.
2003; Meiser and Halliday 2002; Smerecnik et al. 2009);
22 to 50 % of counselees continue to overestimate their
risk (Butow et al. 2003). Moreover, their worry about breast
cancer remains substantial and might be related to a high fre-
quency of breast self-examination (Van Dooren et al. 2003).
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Overestimation of their risk and high cancer worry might lead
to higher use of breast surveillance than recommended.
However, little is known about the adherence to the surveil-
lance recommendation of a large group of counselees, namely
those whowere the first in their family to request breast cancer
genetic counselling and in whom no BRCA1/2 gene mutation
was detected (i.e., they received a BRCA1/2 negative test
result) (Albada et al. 2014; Van Dijk et al. 2006). For these
counselees and for those for whom no DNA-testing is per-
formed, surveillance recommendation depends on the degree
of their pedigree-based risk. A Dutch study found that almost
all counselees with a BRCA1/2 negative test result intended to
have a mammogram in the next year, but their uptake was not
assessed (Van Dijk et al. 2005). An Australian study found
that 86 % of counselees with a pedigree-based risk estimate
had an uptake at the recommended or higher frequency
(Meiser et al. 2001). Notably, overuse of surveillance has
scarcely been assessed. Risk perception, past surveillance up-
take and intention for surveillance have been identified as
predictors of surveillance uptake (Lechner et al. 1997;
Michie et al. 2002). Therefore, counselees’ overestimation of
breast cancer risk (Smerecnik et al. 2009), their surveillance
habits (Meiser et al. 2001) and high intention for surveillance
(Van Dijk et al. 2005) might lead to more frequent mammo-
grams than recommended. This is of concern because of the
risks of early and repeated radiation exposure and the lack of
sensitivity of mammography in young women (Heyes et al.
2009).
The counselees’ personal life story seems to influence their
interpretation of the communicated risk estimate and might
also predict overestimation of risks and surveillance uptake
(Vos et al. 2012). Therefore, some researchers have recom-
mended discussing the counselee’s risk perception in genetic
counseling (Van Dijk et al. 2004a; Michie et al. 2003; Pieterse
et al. 2006). However, studies have shown that counselees’
pre-existing risk perception and interpretation of the risk esti-
mate were rarely discussed (Pieterse et al. 2006). Counselees
did not react to most of the risk estimates given and this might
be related to their low recall (Michie et al. 2005). To date,
counselees’ reactions to the risk estimate in the final visit have
not been a topic of investigation in studies. Counselees’ level
of expressed understanding of this estimate and the surveil-
lance recommendationmight be associated with the alignment
of their post counseling risk perception and adherence.
Moreover, counselees might express their surveillance inten-
tion. Counselors can only tailor their information about
pros and cons of surveillance if counselees express their
(mis)understanding of the risk estimate and recommendation
and if they share their surveillance intentions. This type of
discussion might enhance the quality of an informed decision.
Also, it might enhance counselees’ communication of the risk
estimates to their relatives. Moreover, behavior change (i.e.,
starting or stopping periodic surveillance) is facilitated by
discussing how the change may be undertaken (Gollwitzer
and Sheeran 2006). Spelling out the when, where and how
of the intended behavior is theorized to increase adherence.
The environmental and contextual cues of these details are
expected to prompt the desired behavior. Discussions of the
counselee’s intentions might thus help the counselee to realize
the recommended surveillance uptake.
Purpose of the Study
In this paper we report on a study of the counselees’ expressed
understanding as a response to the risk estimate and surveil-
lance recommendation and whether they express surveillance
intentions in the final consultation for breast cancer genetic
counseling. Associations between the level of understanding,
counselees’ prior surveillance behavior and intentions with
risk perception alignment and surveillance adherence 1-year
post counseling were explored.
Methods
Design
The present study comprises a secondary analysis of data ob-
tained as part of a larger study on breast cancer genetic
counseling at the department of Medical Genetics of the
University Medical Centre Utrecht (UMCU) (Albada et al.
2012). The study was approved by the medical ethical com-
mittee of this hospital. The department of Medical Genetics
offers breast cancer genetic counseling according to the Dutch
guidelines (CBO 2008). Consecutive new counselees were
included from February 2008 to April 2010. Female coun-
selees aged 18 years or older and who were the first of their
first degree family members to seek breast cancer genetic
counseling, were sent information about the study and an
opt-out form. A few counselees were ineligible because
of lack of internet or email access (24 of 371; 6.5 %;
supplementary material Fig. 1). At the start of the consultation
the counselor collected the informed consent form. Both first
and final consultations were videotaped with an unmanned
camera directed at the counselor. After several weeks, a sum-
mary letter of the final consultation was sent to the counselee.
Counselees completed a digital questionnaire before counsel-
ing, approximately 1 week after the final visit and approxi-
mately 1 year after the final visit.
All 14 counselors performing breast cancer genetic
counseling consultations at the department participated and
counseled 2 to 25 counselees each. Counselors were clinical
geneticist (n=3), resident in clinical genetics (n=5), genetic
counselor (n=3) or genetic counselor in training (n=3). Most
were female (n=2 male).
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Sample
The current paper reports on 162 female counselees who re-
ceived an indication for diagnostic DNA-testing for them-
selves or a breast cancer affected relative and/or a follow-up
consultation. For 9 counselees the follow-up consultation was
not videotaped due to logistic failure. For one counselee the
single first consultation was not videotaped due to logistic
failure and there was no follow-up consultation. Thus, the
results concerning the risk communication are based on 152
counselees. Data were initially gathered for a randomized con-
trolled trial of the effects of a pre-visit tailored website on
genetic counseling outcomes for hereditary breast cancer in
which participants were randomized to receive usual care or
usual care plus an educational website. In the current study,
this group allocation was controlled for.
Instrumentation and Procedures
Counselee Characteristics
Having children, family cancer history and educational attain-
ments were assessed in the baseline counselee questionnaire.
The family (cancer) history was derived from the medical file
if missing. Two missing values on education were imputed
with the median. The breast cancer disease status (affected/
unaffected), referral pathway (by GP/medical consultant), in-
dication for DNA-test and test uptake were derived from the
medical file. Counselors rated the counselees’ risk to (re-)de-
velop breast cancer in the future on a scale from 0 to 100 % in
this questionnaire. Their estimation was based on the Claus
tables and the Claus extended formula (Van Asperen et al.
2004).When the risk estimate was revised due to, for instance,
changes in the family cancer history or newly available DNA-
test results, we used the revised risk estimate from the medical
file. For five breast cancer affected counselees with a BRCA1/
2 negative DNA-test result this estimate was missing and was
imputed with the mean estimate for affected counselees with
indication for testing and a BRCA1/2 negative test result.
Counselee Questionnaires
Counselees rated their perceived risk to (re-)develop breast
cancer in the future and this risk for their first degree female
relatives (FDFR) on visual analogue scales from 0 to 100 %.
Risk perception was defined as aligned if the counselee and
counselor estimates were within the same risk category [e.g.
population or slightly increased risk (<20 %), moderate (20–
30 %) or high risk (≥30 %) of developing breast cancer
(again)]. This measure was chosen because the recommenda-
tion for surveillance is based on these risk categories (Van
Dijk et al. 2004a; CBO 2008).
The breast cancer worry in the past 2 weeks was assessed
with the CancerWorry Scale (Van Oostrom et al. 2007). Three
questions assessed the frequency of worry about breast cancer,
influence on mood, and interference with daily activities with
4-point response categories (almost never to almost always).
One item assessed the extent of the worry (1not at all to 4 very
much).
One question assessed how often a woman had performed
breast self-examination (BSE) in the past year. The answer
categories were: no, less than once a month, monthly, weekly,
daily, and not applicable because of risk reducing breast sur-
gery (Van Dijk et al. 2004b).
Intention and adherence to surveillance recommendations
are only reported for breast cancer unaffected counselees.
Affected counselees receive surveillance recommendations
during regular follow-up visits with their surgeon based on
national guidelines (CBO 2008). The post-visit questionnaire
assessed the intention for adherence to the surveillance rec-
ommendation with the following question, BDo you think you
will have a mammogram every year or at least once every
2 years if indicated?^ (Van Dijk et al. 2005). The question-
naires 1 week and 1 year after the final consultation assessed
whether the counselee had risk reducing breast surgery and
whether a woman had a mammogram and/or MRI scan in the
last year (no/yes; if yes, how many times and in which month
and year) (Van Dijk et al. 2004b). Adherence to surveillance
recommendationswas determined by comparing the uptake of
mammography and/or MRI in the last year to the age and risk
specific surveillance recommendations. These recommenda-
tions were based on the Dutch breast cancer guideline (CBO
2008; Supplementary Appendix A). The medical file was
checked to see if the counselor’s recommendation differed
from the guideline recommendation. For some counselees
the counselor had recommended surveillance from a younger
age, and this was incorporated in the determination of these
counselees’ adherence. If the recommendation was to have a
mammogram once every 2 years, the mammography uptake
of the year previously, reported in the questionnaire after the
final consultation, was also considered. Adherence to surveil-
lance recommendations was scored as one in case of agree-
ment, and zero in case of no agreement. Non-adherence was
specified as underuse of surveillance if the counselee had per-
formed no surveillance despite the counselor’s positive advice
given the counselee’s age and risk. If the counselee had per-
formed more mammograms/MRI than recommended or
started at an earlier age than recommended, this was coded
as overuse of surveillance.
Coding of the Videotaped Consultations
The consultations were rated with the RIASgene (Albada et al.
2012), an adaptation for the genetic counseling setting of
Roter’s Interaction Analysis System (RIAS) (Roter 2006).
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This RIAS coding has been shown to have high interrater
reliability (ICC=.86) (Albada et al. 2014). The RIASgene
coding was used to identify counselors’ utterances of the risk
estimate and breast surveillance recommendation for both the
counselee and her relatives. The third author (HD) transcribed
the counselee’s reaction to these utterances and rated: (1) mis-
understanding, (2) general understanding or acceptance, (3)
clear understanding (i.e. a rehearsal of the risk or recommen-
dation in the counselee’s own words or a reflection on its
meaning). Both the wording and tone of voice were taken into
account when coding the reaction. We determined whether the
counselee had given at least one utterance indicating clear
understanding, general understanding and an indication for
misunderstanding (1/0). Additionally, HD checked whether
the counselee had said something about her view on her risk
perception, transcribed it, and coded whether it was concor-
dant with the risk estimate. Furthermore, intentions about sur-
veillance were transcribed and scored for whether they includ-
ed details concerning where, when and how surveillance
would be completed.
Data Analyses
Avariable was created for whether a counselee had uttered at
least one clear understanding of the risk estimate or a state-
ment of concordant risk perception (yes/no). Associations
with risk perception alignment, breast cancer worry and ad-
herence to breast surveillance recommendations were ex-
plored with Chi-square tests. Associations between prior
mammography uptake and adherence and prior breast self-
examination (BSE) uptake and post counseling BSE uptake
were explored with Chi-square tests. Additionally, adherence
to breast surveillance recommendation was the dependent var-
iable in a multilevel regression equation for unaffected coun-
selees with a positive surveillance recommendation. This re-
gression was also performed for unaffected counselees with a
recommendation not to perform surveillance. In both regres-
sion equations the following dependent variables were deter-
mined a priori: past uptake, risk perception alignment, inten-
tion, whether a surveillance recommendation was discussed
and intervention allocation. Intervention allocation had no sig-
nificant association (Chi2 test) with any of the outcome vari-
ables. Counselees were nested within counselors. Analyses
were performed with Stata 11.
Results
Sample Characteristics
The response rate was 58.6 %. Half of the decliners gave a
reason (72/139; 50.4 %, see flowchart Fig. 1). Most preferred
the visit not be videotaped (48/72; 66.7 %). There were no
significant differences between participants and decliners in
age, disease status, family history of cancer and referral path-
way. Most (n=97) counselees had a follow-up consultation,
and 65 counselees had a single consultation (Table 1). For
45.7 % of the counselees there was an indication for DNA-
testing of themselves, and these were primarily breast cancer
affected counselees. For 48.8% of the counselees there was an
indication for DNA-testing for a relative. For 53 (70.7 %) of
the latter counselees, testing was not performed because the
affected relative was not (yet) willing or able to be tested, was
not requested to be tested by the counselee or was deceased.
For the counselees for whom a DNA-test was performed,
81.2 % received a BRCA1/2 negative test result. Counselees
for whom no DNA-test was performed, and those receiving a
BRCA1/2 negative test result, received a pedigree based risk
estimate. None of the counselees had undergone prophylactic
breast surgery pre-counseling.
We conducted a validity check on the self-reported surveil-
lance uptake by comparing this to medical records. Ten breast
cancer unaffected counselees had surveillance in the UMCU
and had completed the question regarding mammography/
MRI uptake. For all of them their self-reported surveillance
uptake was confirmed by the surveillance uptake as registered
(data not shown). Seven of these counselees had performed
surveillance, and this was initiated because of increased risk.
Inter-Rater Agreement
All possible expressions of an intention were discussed by HD
and the first author (AA). For 74 final visits the level of agree-
ment was coded by two coders independently. The percentage
of agreement between the raters for whether the counselee had
expressed clear understanding varied from 70 to 85 %, for
whether the counselee had expressed understanding agree-
ment ranged from 75 to 91 %, and for misunderstanding it
ranged from 83 to 96 %. When the coders did not agree, they
discussed the response and again viewed the video, if needed,
to reach consensus.
Risk Communication
Twenty-three counselees had not received a personal breast
cancer risk estimate in their final consultation (17 unaffected
and 6 affected, Table 2). This was often because further med-
ical information about relatives was needed or there was an
indication for DNA-testing of a relative but this test was not
performed. Approximately one-quarter (24.6 %) of the breast
cancer unaffected counselees, and 35.9 % of the affected
counselees, uttered clear understanding of the risk estimate.
Twenty-five counselees expressed something about their view
on their risk perception in the consultation. For four of them,
their expressed view signaled a misunderstanding or unex-
pectedness of the risk estimate given by the counselor; for
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the others their view signaled understanding of the estimate
(not in Table). Four of the five counselees who had uttered a
misunderstanding of their risk estimate or a discordant risk
perception had misaligned risk perceptions 1 year post-
counseling.
Forty percent of the unaffected counselees uttered a
clear understanding of the surveillance recommendation.
Of the four unaffected counselees who uttered a
disagreement with the surveillance recommendation,
two were adherent 1 year post-counseling. Nine (5.8 %)
counse lees expressed a surve i l l ance in ten t ion
(supplementary material: Fig. 2). Six of them were breast
cancer unaffected. Four counselees expressed an inten-
tion to perform mammogram/MRI to adhere to the
recommendation, and three of them were adherent. One
counselee expressed an intention for mammography up-
take at an earlier age than recommended, and she had
indeed performed a mammogram 1 year post-counseling.
Four intentions included information about when to per-
form the surveillance, and two included information
about where or with which health care provider to ar-
range the surveillance.
Risk Perception and Adherence
Immediately post-counseling about half of the unaffected
counselees (48.6 %) accurately perceived their breast can-
cer risk and 38.6 % overestimated their risk (Table 3).
Table 1 Counselee characteristics
Age (years)*** Unaffected
(n=89)
Affected
(n=73)
Total
(N=162)
M Sd M Sd M Sd
37.9 10.6 47.5 10.3 42.2 11.5
n % n % n %
Children (having children)** 52 58.4 60 82.2 112 69.1
Educationa:
<High school level 2 2.3 0 0.0 2 1.3
High school/ Secondary education 26 29.9 19 26.8 45 28.5
Middle vocational education 25 28.7 23 32.4 48 30.4
University (MSc/BSc)/higher vocational education (BSc) 34 39.1 29 40.9 63 39.9
Referred by GP (vs. consultant)*** 65 73.0 11 15.1 76 46.9
Follow-up consultation (vs. only one consultation)*** 32 36.0 65 89.0 97 59.9
Indication for DNA-testingb 83 93.3 70 95.9 153 94.4
For counselee 8 9.0 66 90.4 74 45.7
Test uptake 3 – 59 – 62 –
For relative 75 84.3 4 5.5 79 48.8
Test uptake 22 – 1 – 23
BRCA1/2-test resultc
BRCA1/2 negative 21 48 69 42.6
BRCA1/2 mutation carriers NA NA 7 7 4.3
50 % risk of being a BRCA1/2 mutation carrierd 3 NA NA 3 1.9
VUCS e 1 1.1 6 8.2 7 4.3
Breast cancer risk category counselee**
Population (<20 % lifetime risk) 35 39.3 44 60.3 79 48.8
Moderate (20–30 % lifetime risk) 42 47.2 15 20.6 57 35.2
High (≥30 % lifetime risk) 12 13.5 14 19.2 26 16.1
Breast cancer risk category FFDR
Population (<20 % lifetime risk) 37 41.6 35 48.0 72 44.4
Moderate (20–30 % lifetime risk) 38 42.7 25 34.3 63 38.9
High (≥30 % lifetime risk) 14 15.7 13 17.8 27 16.7
a 4 missing values; b for 10 counselees there was a second consultation to determine whether there was an indication for DNA-testing and medical file
data from relatives showed that there was none, for 4 of these counselees the counselor had indicated that there was an indication for DNA-testing after
the first consultation; c One test result indicated a BRCA1/2-mutation as well as an unclassified variant; d breast cancer unaffected counselees with a first
degree relative who tested positive for a BRCA1/2 mutation; e Variant of Unknown Clinical Significance; Significant difference between breast cancer
affected and unaffected counselees; t-test and X2 ** p<.01 ***p<.001
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More than half of the affected counselees (65.5 %) cor-
rectly estimated the risk for their FDFR. At 1 year post
counseling there were significantly less counselees with
an accurate risk perception than 1 week post-counseling
(X2= 13.70; p= .000). Most unaffected counselees
(55.1 %) overestimated their risk. More than one-third
of the affected counselees (35.0 %) overestimated the risk
for their FDFR. Having received a personal risk estimate
in the final visit was not significantly related to the risk
perception alignment for themselves (X2=.33; p=.57).
Also, there was no significant association between the
utterance of a clear understanding or concordant risk per-
ception in the visit and the alignment of risk perception
post-visit (X2=1.17; p=.28).
Counselees’ breast cancer worry had lowered from
pre- to post-counseling (1.75 vs. 1.64; t=2.51; p=0.01)
and from pre- to 1 year post-counseling (1.75 vs. 1.64;
t=2.79; p=.006). Their breast cancer worry was not
significantly associated with expressed understanding
of the risk estimate at any of the time points.
Less than one-tenth of the breast cancer unaffected
counselees performed more than monthly BSE
(Table 4). Of the breast cancer affected counselees,
more than one-fifth performed more than monthly
BSE. Post counseling, counselees intended to perform
BSE more frequently than they had done pre-
counseling (n=99; X2=43.6; p=.000) and 1 year post-
counseling the uptake was higher than pre-counseling
(n=128; X2=27.4; p=.000).
Almost half of the breast cancer unaffected counselees had
a mammogram in the year before their first consultation (n=
42; 48.3 %). Post counseling almost all unaffected counselees
(n=73; 91.3 %) intended to have a mammogram/MRI if this
was indicated. One year after the final consultation, almost
Table 3 Risk perception alignment post counseling and 1 year after counseling
Total Accurate perception Overestimation Underestimation
n n % n % n %
After genetic counseling(n=124)
Breast cancer unaffected counseleesa 70 34 48.6 27 38.6 9 12.9
Br risk <20c 28 15 53.6 13 46.4 – –
Br risk 20–30 32 12 37.5 14 43.8 6 18.8
Br risk >30b,c 8 5 – – – 3 –
50 % risk of being BRCA1/2 mutation carrierb 2 2 – 0 – 0 –
Breast cancer affected counselees* 55 36 65.5 9 16.4 10 18.2
Br risk <20c 25 21 84.0 4 16.0 – –
Br risk 20–30 20 10 50.0 5 25.0 5 25.0
Br risk >30b,c 4 2 – – – 2 –
BRCA1/2 mutation carriersb 6 3 – 0 – 3 –
One year after the final visit (N=142)
Breast cancer unaffected counselees a 78 27 34.6 43 55.1 8 10.3
Br risk <20c 30 8 26.7 22 73.3 – –
Br risk 20–30 38 14 36.8 21 55.3 3 7.9
Br risk >30b,c 8 4 – – – 4 –
50 % risk of being BRCA1/2 mutation carrierb 2 1 – 0 – 1 –
Breast cancer affected counselees* 60 31 51.7 21 35.0 8 13.3
Br risk <20c 29 19 65.5 10 34.5 – –
Br risk 20–30 22 5 22.7 11 50.0 6 27.3
Br risk >30b,c 3 3 – – – 0 –
BRCA1/2 mutation carriersb 6 4 – 0 – 2 –
a Including counselees who received an indication for DNA-testing for a relative but no testing was performed, counselees received an uninformative
result and counselees who received a VUCS
bBecause of low numbers no percentages are displayed
c Underestimation of risk category is not possible for counselees in the lowest risk category and overestimation of risk category not possible for
counselees in highest risk category
* For breast cancer affected counselees their perception of the risk for their first degree female relatives was compared to the counselor’s estimate of this
risk
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three quarters of breast cancer unaffected counselees (74 %)
adhered to the genetic counselor’s recommendation (Table 5).
Of the non-adherent counselees, 26 had a mammogram/MRI
scan while this was not recommended by the counselor. Most
of them (n=19) were younger than the recommended age to
start mammography given their risk category. Others (n=7) had
an uptake of two instead of one mammograms/MRI scans in
1 year. Two counselees had not performed amammogram/MRI
scan while this was recommended. There were no significant
differences in adherence between the unaffected counselees
who had received BRCA1/2 negative test result from their
affected relative (n=17) and those in whom no DNA-testing
was performed in relatives (n=49). No significant associations
were found between expressed a clear understanding of the
surveillance recommendation and adherence (X2=.05; p=.83).
In bivariate analysis, the overuse of surveillance of counselees
with a negative surveillance recommendation was associated to
prior mammography uptake (n=47; X2=5.2; p=.02). In the
multilevel multivariate regression analysis, no significant asso-
ciations with adherence were found.
Discussion
This study is the first to explore counselees’ expressed under-
standing of the risk estimate and surveillance recommendation
in the final consultation for breast cancer genetic counseling
counselees. Most counselees responded affirmatively to the
disclosure of their risk estimate and the surveillance recom-
mendation. This might have given counselors the impression
that the counselee perceived her risk in accordance with the
estimate given and would follow-up on the surveillance
recommendation. However, in line with earlier findings
(Butow et al. 2003; Smerecnik et al. 2009), a large percentage
of counselees overestimated their risk post counseling. The
current study showed that counselees’ expressed under-
standing of their risk estimate was not significantly associated
with the post-counseling risk perception alignment and breast
cancer worry. More elaborate exploration of counselees’
beliefs about their risk might be needed to detect this lack of
alignment between counselees’ and counselors’ views during
the final visit.
Table 4 Breast self-examination of breast cancer unaffected and affected counselees before genetic counseling and 1 year after their
final visit (n=158a)
Weekly or more frequently Monthly < Monthly Never
n n % n % n % n %
Before genetic counseling
Breast cancer unaffected counselees 87 6 6.9 33 37.9 36 41.4 12 13.8
Br risk <20 33 2 6.1 15 45.5 13 39.4 3 9.1
Br risk 20–30 41 3 7.3 13 31.7 19 46.3 6 14.6
Br risk >30 10 1 10.0 4 40.0 4 40.0 1 10.0
50 % risk of being BRCA1/2
mutation carrierb
3 0 – 1 – 0 – 2 –
Breast cancer affected counselees 71 11 15.5 20 28.2 27 38.0 13 18.3
Counselees with a pedigree based
risk estimationc
64 11 17.2 17 26.6 25 39.1 11 17.2
BRCA1/2 mutation carriersb 7 0 – 3 – 2 – 2 –
One year after the final visit
Breast cancer unaffected counselees 74 7 9.5 34 46.0 23 31.1 10 13.5
Br risk <20 28 2 7.1 12 42.9 10 35.7 4 14.3
Br risk 20–30 36 3 8.3 19 52.8 10 27.8 4 11.1
Br risk >30b 8 1 – 3 – 3 – 1 –
50 % risk of being BRCA1/2
mutation carrierb
2 1 – 0 – 0 – 1 –
Breast cancer affected counselees 57 13 22.8 23 40.4 16 28.1 5 8.8
Counselees with a pedigree based
risk estimationc,d
53 13 24.5 21 39.6 15 28.3 4 7.6
BRCA1/2 mutation carriersb,d 4 0 – 2 – 1 – 1 –
a Four missing values because the counselee did not complete the question about breast self-examination
b Because of low numbers no percentages are displayed
cMostly after an uninformative DNA-test result
d For two breast cancer affected counselees with a pedigree based risk estimation and two carriers, breast self-examination was non-applicable in the
questionnaire 1 year post counseling because of a performed bilateral prophylactic mastectomy, these counselees are not included in the results at 1 year
after the final visit
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Our results suggest that surveillance uptake is high in the
Netherlands, at least for counselees with BRCA1/2 negative
test-result or with no available DNA-test results for their af-
fected relative. There were only two counselees with lower
surveillance uptake than recommended. Notably, one-quarter
of the counselees performed more surveillance than recom-
mended. These were mainly counselees at slightly or moder-
ately increased risk who started periodic surveillance before
the recommended age of 50 or 40 years, respectively. The
intention for mammography/MRI and overuse of surveillance
compared to the recommendation seem unassociated with
whether counselees’ expressed (mis)understanding in the final
visit. Furthermore, surveillance intentions were scarcely
expressed and included little information about the when,
where and how of the intended behavior. This might have lead
counselors to believe that the counselee intended to follow up
on the surveillance recommendation. Hence, more explicit
exploration of misunderstandings might be needed to explore
intentions.
The need for a more elaborate discussion about coun-
selees’ risk perception in the final visit is underlined by a
significant decrease in accurate risk perception in the year
post counseling. This might indicate that counselees’ per-
ception of their risk drifts further away from the risk es-
timate given by the genetic counselor. Studies with shorter
follow-up periods did not find significant decreases in risk
perception (Pieterse et al. 2011; Van Dijk et al. 2005; Van
Dijk et al. 2006). For the majority of breast cancer unaf-
fected counselees in the current study, the indicated DNA-
test was not performed by their affected relative. Possibly,
in the absence of a DNA-test result, counselees are not
reassured by a pedigree-based low risk estimate and this
lack of reassurance increases in the year post counseling.
For counselees with a negative BRCA1/2 test result inac-
curate beliefs about this test result might be related to
poor adjustment (Van Dijk et al. 2006). Counselors might
thus additionally invite these counselees’ views about the
value of their test results in an attempt to better align the
counselees’ risk perception with the risk estimate.
Studies of genetic counseling in the USA and Australia
found lower surveillance uptake of counselees than recom-
mended (Botkin et al. 2003; Lerman et al. 2000; Meiser
et al. 2001) and this might reflect international differences in
the accessibility of mammography. In the Netherlands, sur-
veillance is covered by (obligatory) health insurance and the
average travel distance to the nearest hospital is small.
Surveillance is dealt with by either a familial cancer center
(Van Dijk et al. 2005), the surgeon, GP or the National
Surveillance Program. These health system characteristics
might lead to relatively high surveillance uptake.
Overuse of surveillance after genetic counseling was not
previously described for counselees receiving a pedigree-
based risk assessment, with or without a BRCA1/2 negative
test result. Lerman et al. (2000) found that 30 % of non-
carriers after predictive BRCA testing had an annual mammo-
gram despite this not being recommended. Michie et al.
(2002) found a similar desire to carry on with surveillance
among counselees for predictive FAP testing who received a
low risk result. Counselees felt that test results might be un-
certain and reported little confidence in a genetic test based on
a blood sample (Michie et al. 2003). This may be especially
true when the test was performed in an affected relative, as
shown by Van Dijk et al. (2008). However, counselees
performing regular mammograms earlier than recommended
might not be aware of radiation risks and the suboptimal sen-
sitivity of mammography in the dense breast tissue of young
women (Heyes et al. 2009).
As a referral is needed for mammography in the
Netherlands, these women were probably referred by their
GP. A Dutch study showed that GPs referred women for a
mammogram despite a negative surveillance recommendation
from the geneticist (De Bock et al. 2001). The GPs’ deviation
from the genetic advice seems understandable as women
might appreciate a mammogram more than reassurance (De
Table 5 Adherence to breast surveillance recommendations of breast
cancer unaffected counselees in breast cancer genetic counseling 1 year
after their last visit (n =75)a
Adherence
n n %
Br risk <20 % 28 22 78.6
Age <50 b,c 27 21 77.8
50–75d 1 1 –
Br risk 20–30 % 36 26 72.2
Age <40 b,c 21 14 66.7
40–50 13 11 84.6
50–75d 2 1 –
Br risk >30 % 7 4 57.1
Age <35b,c,d 3 2 –
35–60d 3 1 –
60–75d 1 1 –
50 % risk of being BRCA1/2 mutation carrierd,e 2 2 –
Total 73 54 74.0
a Including counselees who received an indication for DNA-testing for a
relative but no testing was performed, counselees received an uninforma-
tive result and counselees who received a VUCS. 14 missing values
because the counselee did not complete the question about surveillance
uptake
bAge categories differ per risk category based on the age and risk specific
surveillance recommendations according to the Dutch Breast Cancer
Guideline, see Supplementary Appendix A
c There were no counselees older than 75 in this risk group
d Because of low numbers no percentages are displayed
e The two counselees for whom amutation was found in a relative were in
the age of surveillance recommendation (25–75 years of age)
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Bock et al. 2001), and patients have been reported to put
pressure on their GP to receive a referral (Burke et al. 2009).
Also, referring physicians have been found to underestimate
the radiation risks and did not inform patients about these risks
(Ricketts et al. 2013). As mammography is covered by the
health insurance system in the Netherlands and in many other
countries, overuse could be included in discussions about
health care costs. Opportunities to promote informed decision
making regarding mammography uptake thus occur in both
genetic counseling and GP practice (Sollie et al. 2015).
Counselors’ information about (dis)advantages of mammog-
raphy and explicit invitation of opposing views might enable
counselees to share their surveillance intention.
Study Limitations and Research Recommendations
This study had several limitations. First, the questionnaire
assessed counselees’ intention to perform a mammogram/
MRI scan if it was recommended by the counselor.
However, not all counselees received such a recommendation
as for some, periodic surveillance was not indicated. Follow-
up studies should assess intention in relation to the recommen-
dation received. Second, we cannot be sure whether some
cases of reported overuse of surveillance occurred because
of breast symptoms (e.g., a lump). Third, our questionnaire
did not include questions about how a referral for
mammography/MRI was obtained. However, as a large ma-
jority of the breast cancer unaffected counselees was referred
to genetic counseling by their GP, we assumed that these
counselees also obtained their referral for a mammogram from
the GP. Finally, as only nine counselees expressed their inten-
tion, we lacked power to statistically explore an association
with adherence.
Practice Implications
This study showed that counselees’ risk perceptions and sur-
veillance intentions are infrequently discussed in the final visit
for breast cancer genetic counseling in the Netherlands. More
elaborate discussion of these issues could enable counselors to
discuss the disadvantages of periodic mammography, such as
radiation risks and lack of sensitivity in young women. This
might enable counselees to make a more informed decision.
Moreover, motivational interviewing techniques could help
counselors to discuss counselees’ motivation and intentions
(Rollnick et al. 2010). This would mainly involve exploration
and inviting counselees to elaborate on their attitude towards
and feelings about the surveillance. Furthermore, prior mam-
mography uptake might be associated with overuse of surveil-
lance. Therefore, if a GP is considering sending a young wom-
an for a mammogram based on the cancer family cancer his-
tory, the woman should be referred to genetic counseling first.
Early referral to genetic counseling might help to prevent
establishing a routine of regular mammography uptake with-
out medical rationale.
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